These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 18957117)

  • 1. Careers in ecstasy use: do ecstasy users cease of their own accord? Implications for intervention development.
    Peters GJ; Kok G; Schaalma HP
    BMC Public Health; 2008 Oct; 8():376. PubMed ID: 18957117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MDMA/Ecstasy use among young people in Ohio: perceived risk and barriers to intervention.
    Carlson RG; Falck RS; McCaughan JA; Siegal HA
    J Psychoactive Drugs; 2004 Jun; 36(2):181-9. PubMed ID: 15369199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of a transient instability of the ecstasy market on health concerns and drug use patterns in The Netherlands.
    Brunt TM; Niesink RJ; van den Brink W
    Int J Drug Policy; 2012 Mar; 23(2):134-40. PubMed ID: 21741814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of use and harm reduction practices of ecstasy users in Australia.
    Allott K; Redman J
    Drug Alcohol Depend; 2006 Apr; 82(2):168-76. PubMed ID: 16226850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Avoiding counterproductive results: an experimental pretest of a harm reduction intervention on attitude toward party drugs among users and nonusers.
    Whittingham JR; Ruiter RA; Bolier L; Lemmers L; Van Hasselt N; Kok G
    Subst Use Misuse; 2009; 44(4):532-47. PubMed ID: 19242864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using the Theory of Planned Behavior to predict implementation of harm reduction strategies among MDMA/ecstasy users.
    Davis AK; Rosenberg H
    Psychol Addict Behav; 2016 Jun; 30(4):500-8. PubMed ID: 27322805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome expectancies and ecstasy use in visitors of rave parties in The Netherlands.
    Engels RC; ter Bogt T
    Eur Addict Res; 2004; 10(4):156-62. PubMed ID: 15367816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preventing problems in Ecstasy users: reduce use to reduce harm.
    Baggott MJ
    J Psychoactive Drugs; 2002; 34(2):145-62. PubMed ID: 12691205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-Reported Ecstasy/MDMA/"Molly" Use in a Sample of Nightclub and Dance Festival Attendees in New York City.
    Palamar JJ; Acosta P; Ompad DC; Cleland CM
    Subst Use Misuse; 2017 Jan; 52(1):82-91. PubMed ID: 27661470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Male and female ecstasy users: differences in patterns of use, sleep quality and mental health outcomes.
    Ogeil RP; Rajaratnam SM; Broadbear JH
    Drug Alcohol Depend; 2013 Sep; 132(1-2):223-30. PubMed ID: 23453259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An in-depth qualitative examination of the ecstasy experience: results of a focus group with ecstasy-using college students.
    Levy KB; O'Grady KE; Wish ED; Arria AM
    Subst Use Misuse; 2005; 40(9-10):1427-41. PubMed ID: 16048826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shifting characteristics of ecstasy users ages 12-34 in the United States, 2007-2014.
    Palamar JJ; Mauro PM; Han BH; Martins SS
    Drug Alcohol Depend; 2017 Dec; 181():20-24. PubMed ID: 29028555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mental disorders in current and former heavy ecstasy (MDMA) users.
    Thomasius R; Petersen KU; Zapletalova P; Wartberg L; Zeichner D; Schmoldt A
    Addiction; 2005 Sep; 100(9):1310-9. PubMed ID: 16128720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns and harms of pharmaceutical drug use among ecstasy users in Australia.
    Silins E; Copeland J; Dillon P
    Adicciones; 2009; 21(4):347-62. PubMed ID: 20011991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of peers in the initiation and continuation of ecstasy use.
    Vervaeke HK; van Deursen L; Korf DJ
    Subst Use Misuse; 2008; 43(5):633-46. PubMed ID: 18393081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of reagent test-kit use and perceptions of purity among ecstasy users in an electronic dance music scene in New York City.
    Palamar JJ; Barratt MJ
    Drug Alcohol Rev; 2019 Jan; 38(1):42-49. PubMed ID: 30575155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased cortisol levels in hair of recent Ecstasy/MDMA users.
    Parrott AC; Sands HR; Jones L; Clow A; Evans P; Downey LA; Stalder T
    Eur Neuropsychopharmacol; 2014 Mar; 24(3):369-74. PubMed ID: 24333019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brief interventions to reduce Ecstasy use: a multi-site randomized controlled trial.
    Norberg MM; Hides L; Olivier J; Khawar L; McKetin R; Copeland J
    Behav Ther; 2014 Nov; 45(6):745-59. PubMed ID: 25311285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recreational ecstasy/MDMA and other drug users from the UK and Italy: psychiatric symptoms and psychobiological problems.
    Parrott AC; Milani RM; Parmar R; Turner JD
    Psychopharmacology (Berl); 2001 Dec; 159(1):77-82. PubMed ID: 11797073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sources of information about MDMA (3,4-methylenedioxymethamphetamine): perceived accuracy, importance, and implications for prevention among young adult users.
    Falck RS; Carlson RG; Wang J; Siegal HA
    Drug Alcohol Depend; 2004 Apr; 74(1):45-54. PubMed ID: 15072806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.